BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Cisplatin
,
rs3825942
,
ERBB2
,
G-protein-coupled receptor binding
,
Ischemia
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Cholinesterase
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Thalamus
Thyroid gland
Kidney medulla
Sigmoid colon
Fetal liver
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Infectious disease of lung
Lower respiratory tract infection
Lyme disease
Bovine respiratory syncytial virus disease
Graft versus host disease
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
hexafluorenium
Pyridostigmine Bromide
Echothiophate Iodide
Ambenonium Chloride
demecarium bromide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CCDC170
OTUD5
PCDH11X
SMNDC1
CDX1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Zebrafish larvae, UHRF1 mutant or wildtype
Embryonic gene expression in response to the antineoplastic agent PKC412
Esophageal gene expression in adult wildtype and zCdx1b transgenic zebrafish
Fibroblasts conversion to neurons mediated by transcription factors ASCL1, BRN2 and MYT1L
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Cholinesterase
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cholinesterase Inhibitor Discontinuation
Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
Point of Care Testing of Cholinesterase Activity During Burn- and Polytrauma
Estimation of Functional Liver Reserve Using Cholinesterases
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ